[50] The efficacy and safety of low-intensity shockwave therapy in erectile dysfunction
Riyad Al MousaAbdulrahman AlmuhrijMohammed AlmujhimHassan AlsayeghAbdulmohsin AlfadaghHamed AlaliAdel Aldayel
0
Citation
0
Reference
10
Related Paper
Abstract:
ObjectiveTo assess the effectiveness and safety of low-intensity extracorporeal shockwave therapy (Li-ESWT) on patients with erectile dysfunction (ED).Keywords:
Extracorporeal shockwave therapy
Intensity
Extracorporeal
Cite
Citations (0)
Extracorporeal shockwave therapy
Intensity
Cite
Citations (0)
Extracorporeal shockwave therapy
Intensity
Cite
Citations (0)
Noninvasive low-intensity extracorporeal shockwave treatment (Li-ESWT) has been widely used to treat erection disorders. There is no clear information regarding either the selection of patients for the treatment or the treatment protocol. In this study, we aimed to investigate the efficacy of extracorporeal shockwave therapy in diabetic patients with severe erectile dysfunction (International Index of Erectile Function-5 [IIEF-5] scores of 5 to 7). Sixty-three diabetes mellitus patients with erectile dysfunction having IIEF-5 scores of 5 to 7 and not showing a recovery of potency despite phosphodiesterase type 5 inhibitor therapy for the past 6 months were included in the study. The patients were evaluated based on their IIEF-5 scores and Erection Hardness Scale scores. The IIEF-5 score (mean ± standard deviation [s.d.]) increased from 5.29 ± 1.67 to 5.56 ± 1.85, with a difference of 0.27 ± 0.18 (P > 0.05). The Erection Hardness Scale scores (mean ± s.d.), on the other hand, increased from 1.46 ± 0.50 to 1.48 ± 0.50, with a difference of 0.02 ± 0 (P > 0.05). In conclusion, the response to phosphodiesterase type 5 inhibitors did not change after extracorporeal shockwave treatment in diabetes mellitus patients with severe erectile dysfunction (IIEF-5 scores of 5 to 7).
Extracorporeal shockwave therapy
Extracorporeal
Cite
Citations (7)
The aim of our study was to investigate the effect of antihypertensive treatment on erectile function in patients with essential hypertension. From our hypertension outpatient clinic, 358 consecutive young and middle-aged men (31–65 years old, 49.1±5.2 years) with essential hypertension filled a questionnaire regarding erectile function (International Index for Erectile Function). Antihypertensive therapy significantly affected the erectile function of our patients, with patients on combination therapy exhibiting the higher prevalence of erectile dysfunction. Older antihypertensive drugs exhibit worse profile on erectile function than newer drugs, suggesting that this may be another parameter for the proper choice of antihypertensive drug.
Antihypertensive drug
Pharmacotherapy
Essential hypertension
Cite
Citations (0)
Extracorporeal shockwave therapy
Extracorporeal
Cite
Citations (25)
Low-intensity extracorporeal shockwave therapy similar to that used to fragment kidney stones or gallstones is a new option for treatment of erectile dysfunction that is now being advertised extensively in the US. It has not been approved by the FDA for treatment of erectile dysfunction.
Extracorporeal shockwave therapy
Extracorporeal
Cite
Citations (0)
Cite
Citations (1)
Objectives: To investigate the age-related differences of erectile function and erectile hardness in erectile dysfunction( ED) patients. Method: The data were retrieved in a baseline database on an ED management study which was performed in 46 urological clinics in China. The patients were stratified on the basis of every 10 years( yrs) old. International Index of Erectile Function( IIEF-EF) and Erection Hardness Score were adopted as the scale to evaluate erectile functions and the Erection Hardness Score( EHS). Statistical analysis were then done to make comparisons among different age groups. Results: The study included 4241 ED patients with an age range from 20 to 84 yrs( average 42. 3 ± 12. 3 yrs); 55. 6% patients were between 31 to 50 yrs old. For patients over 30 yrs old,with the increase of age,both scores of IIEF-EF and EHS tended to decrease. Decrease of erectile function and erectile hardness scores were statistically significant between the patients aged over and below 50 yrs, and the conditions were even worse in the patients over 60 yrs. Conclusion: This study suggested that for men below 50 yrs old,prevention and treatment of ED were essential; while for those over 50 yrs old,the treatment of ED and the prevention of its comorbidities were highly recommended.
Cite
Citations (0)